从资金流向上来看，当日医疗器械板块主力资金净流出13.5亿元，游资资金净流入4.26亿元，散户资金净 流入9.24亿元。医疗器械板块个股资金流向见下表： 证券之星消息，1月6日医疗器械板块较上一交易日上涨1.43%，伟思医疗领涨。当日上证指数报收于 4083.67，上涨1.5%。深证成指报收于14022.55，上涨1.4%。医疗器械板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 688580 | 伟恩医疗 | 69.70 | 20.01% | 10.29万 | | 6.98 亿 | | 688626 | 翔宇医疗 | 87.12 | 20.00% | 8.63万 | | 7.42亿 | | 300753 | 爰朋医疗 | 39.96 | 20.00% | 15.74万 | | 6.19亿 | | 301363 | 美好医疗 | 34.63 | 19.99% | - 3.91万 | | 1.36亿 | | 688273 | 麦澜德 | 61.22 | 19.9 ...

脑机接口概念股，热度持续！ 今日（1月6日），A股三大指数集体收涨，A股连续两日超100只个股涨停。截至今日收盘，沪指涨1.5%，报 4083.67点，创10年新高；深证成指涨1.4%，报14022.55点；创业板指涨0.75%，报3319.29点。个股涨多跌少， 超4100股上涨，涨停个股达到120家（不含ST股）。全市场成交额超2.8万亿元，创三个月新高。 继昨日集体大涨后，脑机接口概念股今日再度走强。截至今日收盘，Wind脑机接口指数涨幅超过4%，通达信 人脑工程指数涨幅接近5%，三博脑科、美好医疗、爱朋医疗等近20只相关概念股涨停或涨超10%。其中，爱 朋医疗开盘后直线拉升，1分钟内就封死20%涨停板。 有分析指出，马斯克关于"Neuralink将于2026年启动脑机接口设备大规模量产"的公开表态，使得国内脑机接口 相关公司获得较高的市场关注度。不过，虽然脑机接口产业前景广阔，但不少公司的产品多处于临床阶段，仍 具备不确定性。短期来看，该板块热度过高，需注意部分个股的回调风险。 上述消息，是脑机接口概念股本轮行情的直接催化剂。国金证券表示，在此之前，市场普遍认为脑机接口技术 仍处于实验阶段，商业化前景 ...

Market Overview - The Shanghai Composite Index reached a new high of 4083.67 points, with a daily increase of 1.5% [1] - The total trading volume for the day was 2.81 trillion, an increase of 263.5 billion compared to the previous trading day [1] - The number of advancing stocks was 4,107, while 1,222 stocks declined, with 391 stocks rising over 5% and 28 stocks falling over 5% [1] Market Sentiment - The market is currently in a strong upward trend, with continuous inflow of new capital, indicating no immediate concerns about the current rally [1] - There is an acknowledgment of potential selling pressure and the need for adjustments, but this does not warrant a bearish outlook or reduction in positions [1] Sector Performance - The brain-computer interface sector saw a significant increase of 7.11%, continuing its momentum from the previous day [2] - The non-ferrous metals and chemical sectors experienced notable price increases, with titanium dioxide up 5.85%, copper up 4.11%, and other metals showing similar gains [3] - The non-bank financial sector also performed well, with insurance stocks rising by 4.22% and brokerage firms by 3.53% [3][4] Investment Strategy - Investors are advised to focus on individual stock performance rather than index movements, and to maintain a diversified approach [1] - The current market environment requires a higher tolerance for volatility, as increased trading volume leads to greater fluctuations in individual stocks [1] - The commercial aerospace sector is expected to remain strong, with upcoming satellite launches serving as a significant catalyst for growth [4]

Core Insights - The market experienced a strong performance with 120 stocks hitting the daily limit up, and a total of 43 stocks classified as consecutive limit-up stocks, indicating a bullish sentiment among investors [1] - The advancement rate of consecutive limit-up stocks reached 71.42%, excluding ST and delisted stocks, showcasing a significant increase in market enthusiasm [1] Group 1: Market Performance - Over 4,100 stocks rose in the market, with more than 100 stocks hitting the limit up for the second consecutive trading day [1] - The stock of Victory Energy, which resumed trading, achieved a limit up with a T-shaped pattern, marking its 13th consecutive limit-up [1] - Jia Mei Packaging, which underwent a shareholding change, also saw a limit up, achieving 12 limit-ups over 16 days [1] Group 2: Sector Performance - Resource stocks, particularly in non-ferrous metals and chemicals, showed strong performance, with Luoyang Molybdenum and Zijin Mining both rising over 6% to reach historical highs [1] - Hengli Petrochemical has increased over 20% since December, reaching a nearly four-year high [1] Group 3: Emerging Concepts - The brain-computer interface sector continued its strong momentum, with nearly 20 stocks achieving consecutive limit-ups, including Sanbo Brain Science, Meihao Medical, and Aipeng Medical [1] - The commercial aerospace concept remained active, with notable performances from large-cap stocks such as China Satellite Communications, which achieved 4 limit-ups in 6 days, and Goldwind Technology, which hit a limit up and reached a historical high [1]

Core Viewpoint - The brain-computer interface (BCI) sector is rapidly transitioning from science fiction to reality, with significant market interest and investment from major financial institutions like Goldman Sachs, Morgan Stanley, and Barclays, leading to a notable surge in stock prices within this sector [1][3]. Group 1: Market Performance - On January 5, 2026, the BCI sector in the A-share market experienced a remarkable increase of 13.7%, with 28 concept stocks reaching their daily limit [1]. - The BCI market is projected to have a potential scale of $15 billion to $85 billion in serious medical applications and $25 billion to $60 billion in consumer medical applications [5]. Group 2: Policy and Technological Advancements - Since 2025, there have been numerous positive developments in the BCI field, including clear policy support, successful corporate financing, and significant clinical breakthroughs [3]. - The Ministry of Industry and Information Technology and six other departments have defined BCI as a future industry in 2024, and the National Healthcare Security Administration established independent pricing for BCI technology in March 2025 [3][5]. Group 3: Key Companies and Investments - Five companies in the BCI sector have received substantial investments from foreign institutions, positioning them as core targets in this field [5]. - Innovation Medical is a pioneer in invasive BCI technology, holding a 40% stake in Hangzhou Boling Brain Machine Technology Co., which has developed an upper limb exoskeleton rehabilitation training system [5]. - Aiheng Medical is integrating BCI with artificial intelligence, focusing on pain management and developing a multimodal ADHD training system [9]. Group 4: Clinical Applications and Innovations - Fudan University Huashan Hospital completed the world's first spinal interface surgery, allowing paraplegic patients to regain standing and walking abilities [5][12]. - The BCI technology is being applied in various fields, including rehabilitation, smart living, and human-computer interaction, showcasing its vast potential [12]. Group 5: Investment Trends - In Q3 2025, foreign capital significantly increased its holdings in key BCI companies, with Goldman Sachs increasing its stake in Innovation Medical to 3.3 million shares [5]. - Companies like Taihe Technology and Sanbo Neuroscience are also attracting foreign investments, indicating a growing interest in the BCI sector [7][9].

6日，A股三大指数高开，截至9：50左右，沪指报4054.25点，突破2025年11月14日的阶段高点，刷新2015年7月底以来的新高。 | 上证指数 | 深证成指 | 科创综指 | | --- | --- | --- | | 4054.25 | 13946.42 | 1723.70 | | +30.83 +0.77% +117.79 +0.85% +27.86 +1.64% | | | | 万得全A | 创业板指 | 北证50 | | 6599.79 | 3318.62 | 1482.88 | | +61.85 +0.95% +24.07 +0.73% +16.46 +1.12% | | | | 沪深300 | 中证500 | 中证A500 | | 4762.71 | 7745.80 | 5823.89 | | +44.97 +0.95% | +94.61 +1.24% +60.59 +1.05% | | | 中证1000 | 深证100 | 中证红利 | | 7818.17 | 5966.20 | 5538.87 | | +64.29 +0.83% | +37.87 +0.64% | +13.75 +0. ...

Core Insights - The brain-computer interface (BCI) industry is in its early commercialization stage, with a focus on thematic investment opportunities and the progress of invasive clinical trials [1] - The Chinese BCI market is projected to reach approximately 1.73 billion yuan in 2023, accounting for 12.5% of the global market [2] Group 1: Industry Trends - BCI technology is experiencing a period of accelerated transformation, with various technical paths available, including invasive, semi-invasive, and non-invasive methods, each having distinct advantages in signal quality, safety, and operational difficulty [1] - The development trend in BCI is towards multimodal applications, with existing paradigms categorized into interactive control and state detection types [1] Group 2: Policy Support - The Chinese government has outlined clear support for the BCI industry through planning, payment, and standardization, with a strategic goal set for 2027 and 2030 to foster industry clusters and leading enterprises [2] - In March 2025, the National Healthcare Security Administration established an independent billing item for BCI, providing institutional support for clinical applications [2] - Standards for BCI terminology and data formats have been introduced, reducing costs and risks in technical development and clinical applications [2] Group 3: Technological Advancements and Applications - Core technological barriers in the BCI industry are concentrated in the upstream segment, including hardware (electrodes, chips), surgical procedures, and EEG signal processing [3] - The primary functions of BCI technology encompass monitoring, replacement, recovery enhancement, and supplementation, with a wide range of applications, particularly in the medical field [3] - In 2023, medical applications accounted for 56% of the BCI market in China, focusing on diagnosing consciousness and cognitive disorders, mental illnesses, motor disabilities, and sensory deficits [3]

创新医疗、倍益康、三博脑科、南京熊猫、美好医疗涨停，熵基科技涨超15%，麦澜德、爱朋医疗涨超 10%。 (本文来自第一财经) ...

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Insights - The brain-computer interface (BCI) technology is undergoing a period of accelerated transformation, with various technical paths available, including invasive, semi-invasive, and non-invasive methods, each with its own advantages in signal quality, safety, and operational difficulty [5][19] - The Chinese brain-computer interface market is projected to grow significantly, with the market size reaching approximately 1.73 billion yuan in 2023, accounting for 12.5% of the global market [6] - The industry is supported by a three-pronged policy approach focusing on planning, payment, and standards, which is expected to facilitate rapid development [6][33] Summary by Sections 1. Brain-Computer Interface Overview - BCI is a multidisciplinary technology that integrates neuroscience, computer science, and engineering to enable communication between the brain and external devices [17] - The technology operates through a closed-loop system involving signal input, processing, device control, and feedback [17] 2. Policy Support for BCI Development - The Chinese government has issued several policies to support the BCI industry, including the "Implementation Opinions on Promoting the Innovation and Development of the Brain-Computer Interface Industry" which outlines goals for 2027 and 2030 [6][43] - The policies aim to establish a robust industrial ecosystem, enhance innovation capabilities, and promote clinical applications of BCI technologies [43][44] 3. Technological Advancements and Applications - Core technological breakthroughs are occurring in the upstream segment of the BCI industry, particularly in hardware such as electrodes and chips [7] - The medical application of BCI is predominant, with 56% of the market share in 2023, focusing on various therapeutic areas including cognitive disorders and movement disabilities [7][9] - Companies like Lepu Medical and Aipeng Medical are actively involved in developing deep brain stimulation (DBS) technologies, with some preparing for IPOs [7][8] 4. Investment Recommendations - The report suggests focusing on both invasive and non-invasive BCI products, with specific companies identified as beneficiaries based on their clinical trial progress and commercialization potential [8] - Notable companies include Aipeng Medical and Lepu Medical for invasive products, and Xiangyu Medical and Innovation Medical for non-invasive products [8]

Market Overview - The Shanghai Composite Index (沪指) reached 4057 points, breaking the previous high from November 14, 2025, and marking the highest level since July 2015 [1] - The index has achieved a record of 12 consecutive daily gains, the longest since 1993, with the previous record being 11 consecutive gains [7] Sector Performance - The healthcare sector, particularly companies involved in brain-computer interfaces, saw significant gains with Xiangyu Medical (翔宇医疗) and Aipeng Medical (爱朋医疗) hitting the 20% daily limit up [2][3] - Solid-state battery stocks experienced a surge, with companies like Pulit (普利特) and Jinlongyu (金龙羽) reaching their daily limit up, while others like Aotwei (奥特维) and Daoshi Technology (道氏技术) rose over 10% [3][5] Investment Insights - The solid-state battery market is projected to see demand exceed 150 GWh by 2030, with companies like Donut Lab announcing the first commercially viable solid-state battery at the CES 2026 [6] - Investment recommendations focus on equipment manufacturers capable of complete line delivery and those benefiting from process improvements in solid-state battery production [6]